# REBINYN

NDC: 0169-7901
Generic name: coagulation factor IX recombinant, GlycoPEGylated
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20171201

FDA application: BLA125611

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-7901"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-7901
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ea37235-35fd-410d-b8c4-40ba15fe1294